Showing results (71-80 of 1,759) with videos related to

Sort By:
Pageof 176
Cellular & Molecular Immunology|May 5, 2015
Effect of ebosin on modulating interleukin-1β-induced inflammatory responses in rat fibroblast-like synoviocytesYang Zhang, Lifei Wang, Liping Bai, et al.
Cellular & Molecular Immunology|April 28, 2015
Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellinWei Li, Jingyi Yang, Ejuan Zhang, et al.
Cellular & Molecular Immunology|August 16, 2016
The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathwayRojo A Ratsimandresy, Mohanalaxmi Indramohan, Andrea Dorfleutner, et al.
Cellular & Molecular Immunology|July 21, 2015
MEK2 is a prognostic marker and potential chemo-sensitizing target for glioma patients undergoing temozolomide treatmentHua He, Maojin Yao, Wenhao Zhang, et al.
Cellular & Molecular Immunology|June 2, 2015
Human trophoblast cells induced MDSCs from peripheral blood CD14(+) myelomonocytic cells via elevated levels of CCL2Yun Zhang, Daiwei Qu, Jintang Sun, et al.
Cellular & Molecular Immunology|May 13, 2021
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse modelJaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung-Hoon Jung, et al.
Cellular & Molecular Immunology|May 13, 2021
Dynamic regulation of innate lymphoid cells in the mucosal immune systemFei Shao, Dou Yu, Pengyan Xia, et al.
Cellular & Molecular Immunology|June 7, 2020
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrineSilvia Capellino, Maren Claus, Carsten Watzl
Cellular & Molecular Immunology|August 12, 2021
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumorsZhenguang Wang, Na Li, Kaichao Feng, et al.
Cellular & Molecular Immunology|August 13, 2021
IFNγ signaling integrity in colorectal cancer immunity and immunotherapyWan Du, Timothy L Frankel, Michael Green, et al.
Pageof 176